A safe and sustainable blood supply remains elusive for many low- and middle-income countries (LMICs). The World Health Organization (WHO) considers blood and blood components to be essential medicines, which underscores their importance to health systems. Essential medicines are products that are deemed to be necessary to meet the health care needs of the majority of the population and therefore must be in adequate supply, accessible, and affordable, with their quality assured. Yet nearly two thirds of countries — including countries in central, eastern, and western sub-Saharan Africa, Oceania, and South Asia — lack sufficient blood to meet clinical demand.

Publish Date / Last Revised
September 26, 2024
Search Resources